Wells Fargo Maintains Equal-Weight on Crescent Capital BDC, Lowers Price Target to $18
Portfolio Pulse from Benzinga Newsdesk
Wells Fargo analyst Finian O'Shea maintains an Equal-Weight rating on Crescent Capital BDC (NASDAQ:CCAP) but lowers the price target from $19 to $18.
August 14, 2024 | 12:40 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Wells Fargo analyst Finian O'Shea maintains an Equal-Weight rating on Crescent Capital BDC but lowers the price target from $19 to $18.
The lowered price target from $19 to $18 by Wells Fargo suggests a less optimistic outlook for Crescent Capital BDC, which could lead to a short-term negative impact on the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100